Welcome to our dedicated page for Alchemy Investments Acquisition 1 Units (Proposed) SEC filings (Ticker: ALCYU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Alchemy Investments Acquisition Corp 1 (Nasdaq: ALCYU) provides direct access to the company’s regulatory documents as a special purpose acquisition company in the Financial Services sector. Alchemy has securities registered under Section 12(b) of the Exchange Act, and its filings include current reports on Form 8-K, periodic reports on Forms 10-Q and 10-K, and other submissions such as Form 12b-25 notifications of late filing.
Among the most significant filings are 8-K reports describing material events. One 8-K details shareholder approval of amendments to Alchemy’s Articles of Association that allow the company to extend its deadline to complete a business combination on a month-to-month basis, subject to deposits into its trust account, and reports the resulting redemptions of Class A ordinary shares and the remaining trust balance. Another 8-K outlines the Business Combination Agreement with Cartiga, LLC, including the planned domestication of Alchemy to Delaware, the creation of a holding company (Pubco), the merger structure with Cartiga and the intended Up-C organization of the combined company.
Alchemy’s filings also include a Form 12b-25 (Notification of Late Filing) for a Quarterly Report on Form 10-Q, in which the company explains that it could not file the report by the prescribed due date without unreasonable effort or expense and indicates its expectation to file within the permitted extension period. This type of filing helps investors understand timing and continuity of the company’s financial reporting.
On this page, users can review Alchemy’s 8-Ks for transaction terms, shareholder vote results and extension mechanics, as well as its periodic reports for financial information once filed. AI-powered summaries highlight key provisions, conditions and structural details in lengthy documents such as business combination agreements and charter amendments, helping readers interpret how these filings may affect the ALCYU units, ALCY shares and ALCYW warrants.
Alchemy Investments Acquisition Corp 1 reported shareholder actions from its September 4, 2025 annual meeting. Investors approved a charter amendment allowing the company to extend its deadline to complete a business combination on a month-to-month basis, at the directors’ discretion, through September 9, 2026, by depositing into the trust account the lesser of $30,000 or $0.03 per non-redeemed public Class A share per month. Shareholders also ratified CBIZ CPAs P.C. as independent auditor for the fiscal year ending December 31, 2025.
Following the meeting, the company extended its business combination deadline to October 9, 2025 and deposited $22,126.29 into the trust. In connection with the vote, holders of 324,420 Class A shares elected redemption, leading to the removal of approximately $3,791,334.07 (about $11.68 per share) from the trust. After these redemptions, about $8,619,295.70 remains in the trust account, with 4,208,042 Class A shares and one Class B share outstanding.
The filing is a Form 10-Q for Alchemy Investments Acquisition Corp I (ALCYU) describing its SPAC structure, capital raised and trust mechanics. The company sold 11,500,000 Units (including a 1,500,000 overallotment) for $115,000,000 gross and placed proceeds from the IPO and Private Placement into a Trust Account to be invested in short-term U.S. government obligations or qualifying money market funds. As of June 30, 2025, investments in the Trust Account were reported at $12,252,250 (compared with $11,851,808 at year-end). Founder shares, Private Placement Shares and Public Warrants (exercise price $11.50, five-year term) and redemption mechanics (trigger at $18.00) are described. Promissory notes outstanding increased to $1,130,000 as of June 30, 2025. The Sponsor has conditional indemnity obligations to protect trust funds from certain third-party claims.
The filing excerpt describes transaction documents for Alchemy Investments Acquisition Corp 1 and related parties (ALCY, Pubco, Newco and the Company). It specifies the equity being issued as Class A Ordinary Shares with par value $0.0001 and warrants exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share.
The excerpt sets out termination rights and cure mechanics: either party may terminate the Business Combination Agreement for breaches by the other party, subject to 30-day cure periods where a breach is curable. The Company may also terminate if closing has not occurred by the 45th day after the Registration Statement is declared effective and a specified Available Closing Buyer Cash condition has not been met. The document names Mattia Tomba as Chief Executive Officer of Alchemy Investments Acquisition Corp 1.
The filing is a Form NT 10-Q notice for Alchemy Investments Acquisition Corp 1 (ALCYU) covering the period ended June 30, 2025. The registrant checked the box stating the reason described in Part III could not be eliminated without unreasonable effort or expense, and indicated the accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. The notice includes a signature block signed by Mattia Tomba, Chief Executive Officer. No earnings, financial results, or transaction details are provided in the text supplied.
Alchemy Investments Acquisition Corp 1 (ALCY) is soliciting shareholder votes at an annual general meeting on September 4, 2025 to consider three proposals: a special resolution to extend the date to complete an initial business combination from September 9, 2025 on a month-to-month basis up to September 9, 2026; ratification of CBIZ CPAs P.C. as auditor for the fiscal year ending December 31, 2025; and an adjournment proposal.
The extension would permit the Sponsor, Alchemy DeepTech Capital LLC, to deposit the lesser of $0.03 per non‑redeemed Public Share or $30,000 per one‑month extension period into the Company’s trust account, repayable upon consummation of a business combination. The proxy discloses that IPO and private placement proceeds of $116,725,000 were placed in the trust, that approximately $114,357,720 was removed for prior redemptions leaving approximately $11,634,723 in the trust, and that on the record date there were 4,532,462 Class A Shares and 1 Class B Share outstanding. Public shareholders retain redemption rights if the Extension Proposal is approved.